Nrf2 activation by specific chemicals prevents or inhibits the progression of oxidative stress-related disorders, including diabetes, cancer, cardiovascular diseases, neurodegenerative diseases, chronic obstructive pulmonary disease, pulmonary fibrosis, and inflammation in experimental animal models. Here, NFE2L2 is linked to diabetes mellitus.